GILD vs GSK

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jun 27, 2026

GILD

63.5
AI Score
VS
GSK Wins

GSK

64.1
AI Score

Investment Advisor Scores

GILD

64score
Recommendation
BUY

GSK

64score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric GILD GSK Winner
Forward P/E 15.2207 21.7391 GILD
PEG Ratio 2.1441 19.5996 GILD
Revenue Growth 4.4% 1.5% GILD
Earnings Growth 54.8% 8.4% GILD
Tradestie Score 63.5/100 64.1/100 GSK
Profit Margin 31.0% 17.8% GILD
Beta 1.00 1.00 Tie
AI Recommendation BUY BUY Tie

Frequently Asked Questions

Based on our detailed analysis, GSK is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.